CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Increase in funding for R&D activities pertaining to gene therapy
3.4.1.2. Rise in prevalence of cancer, viral infection, and genetic disorders
3.4.1.3. Increase in awareness regarding gene therapy

3.4.2. Restraints

3.4.2.1. High cost associated with gene therapies
3.4.2.2. Risk of mutagenesis and other impediments in gene therapy

3.4.3. Opportunities

3.4.3.1. Increasing demand for synthetic genes
3.4.3.2. Untapped potential for emerging markets

CHAPTER 4 VIRAL VECTOR AND PLASMID DNA MANUFACTURING MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. VIRAL VECTORS

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.3. PLASMID DNA

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. NONVIRAL VECTORS

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

CHAPTER 5 VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. CANCERS

5.2.1. Market size and forecast

5.3. INHERITED DISORDERS

5.3.1. Market size and forecast

5.4. VIRAL INFECTIONS

5.4.1. Market size and forecast

5.5. OTHERS

5.5.1. Market size and forecast

CHAPTER 6 VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET, BY GEOGRAPHY

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast, by product
6.2.3.2. U.S. market size and forecast, by application
6.2.3.3. Canada market size and forecast, by product
6.2.3.4. Canada market size and forecast, by application
6.2.3.5. Mexico market size and forecast, by product
6.2.3.6. Mexico market size and forecast, by application

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast, by product
6.3.3.2. Germany market size and forecast, by application
6.3.3.3. France market size and forecast, by product
6.3.3.4. France market size and forecast, by application
6.3.3.5. UK market size and forecast, by product
6.3.3.6. UK market size and forecast, by application
6.3.3.7. Italy market size and forecast, by product
6.3.3.8. Italy market size and forecast, by application
6.3.3.9. Spain market size and forecast, by product
6.3.3.10. Spain market size and forecast, by application
6.3.3.11. Rest of Europe market size and forecast, by product
6.3.3.12. Rest of Europe market size and forecast, by application

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. China market size and forecast, by product
6.4.3.2. China market size and forecast, by application
6.4.3.3. India market size and forecast, by product
6.4.3.4. India market size and forecast, by application
6.4.3.5. Japan market size and forecast product
6.4.3.6. Japan market size and forecast application
6.4.3.7. Australia market size and forecast product
6.4.3.8. Australia market size and forecast application
6.4.3.9. South Korea market size and forecast product
6.4.3.10. South Korea market size and forecast application
6.4.3.11. Taiwan market size and forecast product
6.4.3.12. Taiwan market size and forecast application
6.4.3.13. Rest of Asia-Pacific market size and forecast, by product
6.4.3.14. Rest of Asia-Pacific market size and forecast, by application

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast, by product
6.5.3.2. Brazil market size and forecast, by product
6.5.3.3. South Africa market size and forecast, by product
6.5.3.4. South Africa market size and forecast, by application
6.5.3.5. Saudi Arabia market size and forecast, by product
6.5.3.6. Saudi Arabia market size and forecast, by application
6.5.3.7. Rest of LAMEA market size and forecast, by product
6.5.3.8. Rest of LAMEA market size and forecast, by application

CHAPTER 7 COMPANY PROFILES

7.1. BRAMMER BIO, LLC

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Key strategic moves and developments

7.2. THE CELL THERAPY CATAPULT LIMITED

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Key strategic moves and developments

7.3. COBRA BIOLOGICS LTD

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Key strategic moves and developments

7.4. FINVECTOR VISION THERAPIES LIMITED

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio

7.5. FUJIFILM HOLDINGS CORPORATION (FUJIFILM DIOSYNTH BIOTECHNOLOGIES)

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product Portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments

7.6. KANEKA CORPORATION (KANEKA EUROGENTEC S.A.)

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance

7.7. MASSBIOLOGICS

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio

7.8. SANOFI

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance

7.9. SPARK THERAPEUTICS, INC.

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance

7.10. UNIQURE N.V.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance